Custom Tablet Manufacturers — CSK Biotech CDMO Solutions
CSK Biotech delivers high-capacity, regulatory-approved custom tablet manufacturing for global nutraceutical and health brands. With a GMP-certified 2,000㎡ facility, seven advanced production lines and annual capacity exceeding 1.5 billion tablets, we provide end-to-end CDMO services — from formulation and pilot testing to regulatory registration, packaging and timely large-scale production. Partner with CSK for flexible OEM, CDM and ODM models, robust quality systems (GMPC, FDA, HACCP, ISO), and responsive technical support for market-ready tablets.
Why custom tablets matter for CSK Biotech
Tablets remain one of the most trusted delivery forms in the nutritional supplements market because they combine stability, dose accuracy and cost-effective logistics. For brands, choosing the right manufacturing partner goes beyond price — it impacts product efficacy, shelf life, compliance and the speed with which you can scale into new markets. CSK Biotech focuses on translating your product concept into reliable tablet formats that preserve active ingredients, control release where needed, and meet consumer expectations for taste, size and dissolution.
We design tablet solutions that address common real-world challenges: ensuring ingredient uniformity for multi-nutrient formulas, maintaining potency across shelf life for sensitive botanicals, and optimizing tablet hardness for packaging and shipping. That practical, consumer-facing perspective helps brands keep returns low, regulatory risk minimal, and customer satisfaction high.
Our manufacturing capabilities and what sets CSK apart
CSK Biotech’s manufacturing footprint is built for both agility and scale. Our seven advanced production lines and multi-million-unit annual capacity let us handle single-SKU pilot runs and full-scale rollouts with the same quality controls. Core service strengths include:
- Comprehensive tablet technologies — direct compression, wet granulation and dry granulation — to accommodate powders with varying flow and compression characteristics.
- End-to-end support — formulation development, stability verification, pilot batches, scale-up, and full production — delivered under clear timelines and QA checkpoints.
- Packaging and finishing — free basic packaging services and options for customized labeling, blisters, bottles and compliance-ready artwork for export markets.
Every production step is governed by traceable quality systems. Our facility operates under GMP certification and adheres to international standards including GMPC, FDA, HACCP and ISO. That infrastructure not only ensures batch consistency and safety, but also simplifies regulatory submissions and global market entry for our partners.
CDMO partnership models: ODM, CDM and OEM
CSK Biotech offers three cooperation paths tailored to where you are in your product journey:
- ODM (Original Design Manufacturer) — Ideal for brands seeking market-driven innovation. We propose finished product concepts, perform market-relevant formulation adjustments and provide turnkey support to accelerate launch timelines.
- CDM (Custom Design Manufacturing) — For partners needing bespoke formulations and product differentiation. Our R&D team collaborates on ingredient selection, dosage forms and functional claims while protecting intellectual property through NDA processes.
- OEM (Original Equipment Manufacturer) — For clients with established formulas who need precision production and timely delivery. We reproduce formulas at scale with strict batch-to-batch fidelity and documentation for quality assurance.
Across all models, CSK provides pilot testing, stability studies, production batch records and regulatory documentation templates to streamline approvals. Our technical service teams are available to help optimize tablet design for cost, manufacturability and consumer acceptance.
Trust, compliance and support you can count on
Founded in 2008, CSK Biotech combines scientific capability with manufacturing scale. Our 2,000㎡ GMP-certified facility and certifications from GMPC, FDA, HACCP and ISO reflect a commitment to industry-leading safety and quality controls. We back every collaboration with rigorous in-house QA/QC testing, documented traceability and proactive regulatory support — from ingredient qualification to export documentation.
For many partners, the value of a manufacturing relationship also lies in predictable timelines and transparent communication. CSK offers clear project milestones, sample and pilot timelines, and production forecasts so marketing, logistics and regulatory teams can plan with confidence.
Ready to discuss custom tablet production? Visit https://www.cskbiotech.com/ or contact steve@cskbiotech.com for product consultation, formulation inquiries and pricing. Whether you need a single pilot batch or continuous large-scale runs, CSK Biotech combines technical depth, manufacturing capacity and compliance to bring your tablet products to market efficiently and reliably.
FAQ
What minimum order quantities (MOQs) does CSK Biotech require for custom tablet production?
MOQs depend on formulation complexity, tablet size and packaging. Typical pilot runs can start at small SKU quantities, while commercial production MOQs often range from moderate to large volumes. Because CSK Biotech operates high-capacity lines and offers flexible CDMO models, exact MOQs are set case-by-case — contact steve@cskbiotech.com with your formula and target packaging to receive a tailored MOQ estimate.
How long does it take to develop and manufacture a new tablet product?
Timelines vary by project scope. A basic formulation and pilot batch can take several weeks (commonly 4–8 weeks), while full development including stability testing and regulatory documentation can extend to multiple months. Once a formula is finalized, production lead times for commercial batches depend on order size and line scheduling. CSK provides milestone-based timelines during project scoping to help brands plan launches and inventory.
Which certifications and quality controls are in place at CSK Biotech?
CSK Biotech manufactures in a GMP-certified 2,000㎡ facility and adheres to GMPC, FDA, HACCP and ISO standards. Quality management includes raw material qualification, in-process controls, finished product testing, and documented batch traceability. These systems support compliance for domestic and international markets and help reduce regulatory risk for brand partners.
Can CSK Biotech protect my formulation and intellectual property?
Yes. CSK offers confidential development under non-disclosure agreements and supports multiple cooperation models (ODM, CDM, OEM) so partners can choose the level of IP protection and development involvement. During CDM engagements, the R&D process and documentation are structured to safeguard proprietary formulations and manufacturing methods.
Do you support regulatory registration and packaging for export markets?
CSK Biotech provides regulatory support, stability data and documentation templates to assist with market registration. We also supply basic packaging services and can customize labeling, cartons and compliance-ready artwork for target markets. For complex regulatory pathways or country-specific dossier requirements, our technical team works with clients to deliver the necessary documentation and testing support.
cskmanufacture
CSK Biotech Dietary Supplements
Guangzhou Changshengkang Biotechnology Co.,Ltd